Oxycodone/Naloxone Mundipharma 10 mg/5 mg

Oxycodone/Naloxone Mundipharma 10 mg/5 mg is a medicine authorised by Swissmedic under authorisation number 69358. The authorisation holder is Mundipharma Regulatory GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A+: Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material. First authorisation was granted on 17 May 2023 and the authorisation is valid without a time limit. The export lists no ATC code for this medicine.

  • Dispensing category A+
  • Authorisation number 69358
  • Synthetic medicines
Authorisation data
Authorisation number69358
NameOxycodone/Naloxone Mundipharma 10 mg/5 mg
Full nameOxycodone/Naloxone Mundipharma 10 mg/5 mg, Retardtabletten
Authorisation holderMundipharma Regulatory GmbH
Medicinal product codeSynthetic medicines
Dispensing categoryA+ · Prescription with conditions
ATC codenot stated
First authorisation17 May 2023
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Oxycodone/Naloxone Mundipharma 10 mg/5 mg, RetardtablettenA+17 May 2023
2Oxycodone/Naloxone Mundipharma 20 mg/10 mg, RetardtablettenA+17 May 2023
3Oxycodone/Naloxone Mundipharma 5 mg/2.5 mg, RetardtablettenA+17 May 2023
4Oxycodone/Naloxone Mundipharma 40 mg/20 mg, RetardtablettenA+17 May 2023

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
The Swissmedic export lists no pack sizes for this medicine.

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Oxycodone/Naloxone Mundipharma 10 mg/5 mg authorised in Switzerland?

Yes. Oxycodone/Naloxone Mundipharma 10 mg/5 mg is authorised by Swissmedic under authorisation number 69358, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Oxycodone/Naloxone Mundipharma 10 mg/5 mg have?

Oxycodone/Naloxone Mundipharma 10 mg/5 mg is in dispensing category A+. Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material.

Who is the authorisation holder of Oxycodone/Naloxone Mundipharma 10 mg/5 mg?

The authorisation holder is Mundipharma Regulatory GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com